Baxter International Inc (BAX)

$17.31 -0.58 (-3.24%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	9.05B
Revenue (ttm)	11.24B
Net Income (ttm)	-957.00M
EPS (ttm)	N/A
PE Ratio	8.65
Forward PE	9.38
Profit Margin	-8.51%
Debt to Equity Ratio	1.57

Volume	7,896,722
Avg Vol	8,583,274
Day's Range	N/A - N/A
Shares Out	516.47M
Stochastic %K	90%
Beta	0.62
Analysts	Sell
Price Target	$20.55

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed system...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 224 948 2000

Website: www.baxter.com

Address:

One Baxter Parkway, Deerfield, United States